PROVIDER PROFILE · NPI 1154327518
Mark DebruinD.O.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
768
Unique beneficiaries
—
Total services
4,139
Distinct HCPCS
10
Medicare payment
$219K
Peer benchmark
Total Medicare services vs. 8,228 Family Practice providers in CA — top quintile (cohort median 411).
PRESCRIBING · PART D · 2024
Total Rx claims
5,174
Beneficiaries
—
Total drug cost
$509K
Distinct drugs
94
Brand share
27.2%
Top prescribed drugs
Atorvastatin Calcium349 claims
Hydrocodone/Acetaminophen317 claims
Lisinopril303 claims
Amlodipine Besylate270 claims
Levothyroxine Sodium257 claims
QUALITY · MIPS · 2024
Final MIPS score
27.2
Quality
15.0
Cost
70.6
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-5.74%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
68
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
Home health agency
Hospital
REFERRAL NETWORK
Where Mark Debruin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · Sacramento, CA | 89 | 484 |
| DIGNITY HEALTH | 14 | 59 |
| PATH LABS, LLC | 13 | 33 |
| Laboratory Corporation Of America Clinical Laboratory · San Diego, CA | 11 | 41 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE